Author:
Madu M. F.,van de Wiel B.,van Akkooi A. C. J.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Holtkamp LH, Wang S, Wilmott JS, Madore J, Vilain R, Thompson JF, et al. Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (< 0.1 mm) sentinel lymph node metastases. Ann Surg Oncol. 2015;22:2972–77.
2. Cochran AJ. Identification, clinical significance, and management of very small melanoma metastases in sentinel lymph nodes. Ann Surg Oncol. 2015;22:2812–14.
3. Van Akkooi AC, Rutkowski P, van der Ploeg IM, Voit CA, Hoekstra HJ, Nieweg OE, Schäfer-Hesterberg G, et al (2009) Long-term follow-up of patients with minimal sentinel node tumor burden (< 0.1 mm) according to Rotterdam criteria: a study of the EORTC Melanoma Group. J Clin Oncol. 27(Suppl):15 s.
4. van der Ploeg AP, van Akkooi AC, Haydu LE, Scolyer RA, Murali R, Verhoef C, et al. The prognostic significance of sentinel node tumour burden in melanoma patients: an international, multicenter study of 1539 sentinel node-positive melanoma patients. Eur J Cancer. 2014;50:111–20.
5. van der Ploeg AP, van Akkooi AC, Rutkowski P, Nowecki ZI, Michej W, Mitra A, et al. Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol. 2011;29:2206–14.